0001013946 sample contracts and agreements. Interest Transferring Agreement Party A: Hubei Zenith Airbeck Pharmaceutical Co., Ltd. Party B: Hubei Pharmaceutical Group Ltd. U.S.A. Party C: Xiangfan Sanli Company of Hubei Zenith Group
u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended april 30th, 2003 commission file no. 0-25553 hubei pharmaceutical group ltd.
The company reports that in an ongoing effort to work with its partner Hubei Zenith Airbeck Pharmaceutical Company (Airbeck) to optimize the use of available ... the …
The company was founded in 1968 and is based in Xiangfan, China. digitGaps report on Hubei Zenith Airbeck Pharmaceutical Company delivers a detailed in-depth and …
NEW YORK, July 10, 2003 (PRIMEZONE) -- Hubei Pharmaceutical Group, Ltd. (OTCBB:HBEI), Hubei Zenith Airbeck Pharmaceutical Co. Ltd. (Airbeck) and Hubei Pharmaceutical Co. Ltd. (HBJV) are pleased to ...
Hubei Zenith Airbeck Pharmaceutical. Manufacturing · China · <25 Employees . It is a modern pharmacy enterprise that integrates medicine, production and sales. We have advanced equipment, complete detecting instruments, erfect QC system. We are approved by all government structures .
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-KSB [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: JANUARY 31, 2004 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES …
united states securities and exchange commission washington, dc 20549 form 10-ksb [x] annual report under section 13 or 15(d) of the securities exchange act of
10qsb 1 doc1.txt u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended april 30th, 2003 commission file no. 0 …
Explore Hubei Zenith Airbeck Pharmaceutical Co. Ltd. with its drug pipeline, therapeutic area, technology platform, .
ChinaDirectory - directory of China internet websites listings for companies, manufacturers, factories,products, suppliers, traders, importers, exporters, commercial organisations, providing business information and contacts for global buyers.
Issuers Telephone Number: 604-881-2899. Securities registered under Section 12(b) of the Exchange Act: None. Securities registered under Section 12(g) of the Exchange Act: Common
Apotex NZ Ltd Private Bag 102995 North Shore Mail Centre AUCKLAND 0745 : Approval lapsed Approval date: 24/6/1997 Notification date: 15/3/2012: ... Hubei Zenith Airbeck Pharmaceutical Co Ltd. 46 Xianshan Road Xiangfan Hubei 441023 China : Excipient : Colloidal silicon dioxide : Croscarmellose sodium : Lactose monohydrate :
HUBEI PHARMACEUTICAL GROUP, LTD. (Formerly Explore Technologies, Inc.) (A Development Stage Company) CONSOLIDATED BALANCE SHEET AT APRIL 30, 2003 AND APRIL 30, 2002 ...
VANCOUVER BRITISH CO A1 999999999 SECURITIES AND EXCHANGE COMMISSION FORM 10KSB Annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405] Filing Date: | Period of Report: SEC Accession No. 0001012182 (HTML Version on secdatabase) FILER HUBEI …
contact SBM; lafarge aggregates ... hubei sbm airbeck pharmacuetical co ltd contact; shanghai co ltd contact; nfc africa copper mines contact details; ... Vietnam office: …
Hubei Zenith Airbeck Pharmaceutical Co., Ltd. Link ID: 63049: Title: Hubei Zenith Airbeck Pharmaceutical Co., Ltd. Url: : Description: …
10qsb 1 doc1.txt u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended july 31st, 2003 commission file no. 0 …
Hubei Zenith Airbeck Pharmaceutical Company manufactures pharmaceutical products. In addition it exports its products to markets such as America, South-East Asia, Europe, and Japan. Hubei Zenith was formerly known as Hubei Pharmaceutical Factory. The company was founded in 1968 and is based in Xiangfan, China. digitGaps report on Hubei Zenith …
About us. Products. Buy. Sell. Contact us. Chinese. Hubei Xinkang Pharmaceutical Chemical Co.,Ltd.is a large pharmaceutical chemical company which engaged in the R …
NEW YORK, July 10, 2003 (PRIMEZONE) -- Hubei Pharmaceutical Group, Ltd. (OTCBB:HBEI), Hubei Zenith Airbeck Pharmaceutical Co. Ltd. (Airbeck) and Hubei …
View Explore Technologies Inc contracts and agreements from SEC filings. Including company executives, business partners, clauses and more.
u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended april 30th, 2004 commission file no. 0-25553 hubei pharmaceutical group ltd.
table of contents part 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 item 1 description of business ...
Tianjin Tianyao Pharmaceuticals Co Ltd 91 Cheng Lin Zhuang Road Hedong District Tianjin 300161 China : Hubei Zenith Airbeck Pharmaceutical Co Ltd. 46 Xianshan Road …
Hubei Zenith Airbeck Pharmaceutical. Contact us. Company is located in China. Hubei Zenith Airbeck Pharmaceutical TOP partners: Use filtering, Hubei Zenith
NEW YORK, July 10, 2003 (PRIMEZONE) -- Hubei Pharmaceutical Group, Ltd. (OTCBB:HBEI), Hubei Zenith Airbeck Pharmaceutical Co. Ltd. (Airbeck) and Hubei Pharmaceutical Co. Ltd. (HBJV) are pleased to announce the completion of the transfer of the Airbeck dosage division's assets to the new HBJV joint venture between HBEI and …
Hubei Fangtong Pharmaceutical Co.,Ltd, China Experts in Manufacturing and Exporting pharmaceutical intermediate, steroid hormone Company Profile Contact Hubei province, China, on the south bank ofYangtze River, covers the area of 300000 square meters, owns the total assets of 200 million CNY, with the convenient transportation by
Management believe that the transaction is very much in the company's favor although the overall valuation remains fixed at 30,000,000 RMB as Airbeck's contribution to the capitalization of the joint venture. For production purposes, the licenses remain registered with the SFDA for the exclusive use of Hubei Pharmaceutical Company.
10qsb 1 doc1.txt u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended october 31st, 2003 commission file no. 0 …
OTHER EVENTS PRIVATE PLACEMENT - On July 31st, 2003 Hubei Pharmaceutical Group, Ltd. (the "Company") closed on a private placement of 693,333 units at a price of $0.30 each consisting of one share of common stock and one warrant to purchase an additional share of common stock at a price of $0.80 if exercised on or before July 31st, …
EX-1 3 doc2.txt FURTHER RESOLVED that the President of the Corporation be given the authority to take the necessary actions to put the abovementioned resolutions into effect
10KSB 1 doc1.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-KSB [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: JANUARY 31, 2004 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE …
중타르타르산 콜린로의 비즈니스 여행을 생각하고 계십니까? IndustryStock의 제품과 서비스 검색은 중타르타르산 콜린에 대한 관련 검색결과를 제공합니다. 중타르타르산 콜린 이외에도 기타 다른 제품과 서비스를 검색하실 수 있습니다. 중타르타르산 콜린에 대한 등록된 제조업체와 배급업체의 모든 ...